📰 Mathilde Bohin News
Page 2 - Mathilde Bohin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mathilde Bohin. Real-time updates on events, politics, business and more.
October 4, 2022
Direct listing of OPM on Euronext Access Paris on 5 October 2022 Q&A available (only in French): click here Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63;
September 30, 2022
Each Oncodesign shareholder will receive one OPM share for one ONCODESIGN share held Regulatory News: Oncodesign's (Paris:ALONC) General Meeting held on September 30, 2022, authorised the
September 28, 2022
IPO planned at a reference price of €0.817 per share Fundraising of €8 million, guaranteed by OPM's management, planned before the end of 2022 Availability of the Disclosure Document
September 26, 2022
CTA1 approval by the ANSM2 and the EC3 of the phase 1 program resulting from the collaboration between Servier and Oncodesign Precision Medicine for the development of an innovative treatment in Parkinson's
September 20, 2022
Sharp increase in revenue for the first half of 2022 of +58%, to €4.1 million (vs. H1 2021) 52% increase in gross margin in the first half of 2022, to €2.6 million Removal of the conditions
September 19, 2022
Fulfillment of all the conditions precedent, enabling the commercial, technological, and financial partnership with Sanyou Medical to be implemented Regulatory News: IMPLANET (Euronext Growth:
July 12, 2022
Regulatory News: SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants
July 1, 2022
The planned transactions are as follows: The subsidiarisation by ONCODESIGN of its Biotech/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary
July 1, 2022
The planned transactions are as follows:The subsidiarisation by ONCODESIGN of its Biotech/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary, and the listing of this subsidiary through an exceptional distribution in kind to ONCODESIGN's shareholders concomitant w...
June 29, 2022
Commercial partnership: Agreement to distribute Implanet's JAZZ platform in China, the world's largest market (by volume) for spine surgery Technological partnership: Joint development of